C. Satish Chandran

Biography

Dr. Satish Chandran is the Chief Executive Officer of Akshaya Bio Inc. and also serves as Chief Executive Officer of Somahlution Inc. Dr. Chandran is a distinguished biotech veteran with nearly 25 years of significant leadership experience in biotechnology. Previously, Dr. Chandran was Director of the Center for Excellence for Biopharmaceutical Research & Development and Professor of Pharmaceutics at North Dakota State University, the Chief Technology Officer of the Nucleic Acid-Based Therapeutics Unit in the BioTherapeutics Division at Pfizer, in Cambridge MA. While at Pfizer, he was also Professor at the Institute for Hepatitis and Virus Research in Doylestown, PA, USA. He was also Chief Operating Officer and Chief Scientific Officer at Nucleonics, in Horsham PA, the first RNAi based Biotechnology Company he co-founded while on the faculty at Thomas Jefferson University's Biochemistry Department. Prior to founding Nucleonics, Dr. Chandran headed up the DNA Vaccine Division of Wyeth-Lederle Vaccines (following acquisition of Apollon, a biotech company in Malvern, PA), where his group advanced multiple DNA vaccine-based product candidates in infectious diseases and cancer into clinical studies. Dr. Chandran received his Ph.D. from Memorial University in Newfoundland, Canada, and completed a post-doctoral fellowship at Fox Chase Cancer Center in Philadelphia. He is a strategic consultant and a member of the Board of Directors for several emerging and established biotechnology companies.

Research Interest

Biochemistry